MAIA Biotechnology raises ~$1.43M private placement, total $4.1M from two deals

MAIA Biotechnology, Inc.

952,300 shares at $1.50 each; warrants exercisable at $1.85 for 6 years, starting 1 year post-issuance.
Company directors participate (58,333 shares); proceeds to fund Part C of Phase 2 THIO-101 trial and working capital.
Combined gross proceeds from this and a separate $2.7M placement (closed Feb 24) reach $4.1M.
Private placement expected to close on or about February 26, 2025, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.